E2F2 Enhances the Chemoresistance of Pancreatic Cancer to Gemcitabine by Regulating the Cell Cycle and Upregulating the Expression of RRM2

The effect of E2F2 on the proliferation and cell cycling of pancreatic cancer cells was analyzed by tissue culture and flow cytometry.
[Oncology Letters]
Full Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News